Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Big Dam at .28
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(180)
•••
Comment by gordo323on Jan 22, 2025 4:37pm
120 Views
Post# 36415875

RE:RE:RE:Big Dam at .28

RE:RE:RE:Big Dam at .28
BlueFranky wrote: Thanks Dawg

... would be interesting to see market depth  




 
Theralase Technologies Inc. (CA:TLT)
Size Bid Ask Size
3500 0.265 0.270 84000
22000 0.260 0.275 332000
12000 0.255 0.280 11500
40000 0.250 0.290 12000
72000 0.245 0.295 2000
Previous 10 Trades
Time Size Price
15:56:05      15000    0.265
14:44:25 5000 0.270
14:44:09 20000 0.270
10:20:42 1000 0.270
10:13:53 6000 0.270
10:13:53 2500 0.270
09:30:00 1000 0.280
09:30:00 500 0.280

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities